Lobbying Relationship

Client

The Advertising Coalition

More records

Lobbying firm

Polsinelli PC

More records

  • FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act

Duration: to

General Issues: Advertising

Spending: about $2,810,000 (But it's complicated. Here's why.)

Agencies lobbied since 2016: U.S. Senate, House of Representatives, Treasury - Dept of

Bills mentioned

H.R.1776: Improving Access To Affordable Prescription Drugs Act

Sponsor: Jan Schakowsky (D-Ill.)

S.771: Improving Access To Affordable Prescription Drugs Act

Sponsor: Al Franken (D-Minn.)

H.R.2439: Fair Accountability and Innovative Research Drug Pricing Act of 2017

Sponsor: Jan Schakowsky (D-Ill.)

S.1131: Fair Accountability and Innovative Research Drug Pricing Act of 2017

Sponsor: Tammy Baldwin (D-Wis.)

S.1348: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive...

Sponsor: Ron Wyden (D-Ore.)

H.R.1741: Truth in Healthcare Marketing Act of 2015

Sponsor: Larry Bucshon (R-Ind.)

H.R.4565: Responsibility in Drug Advertising Act of 2016

Sponsor: Rosa DeLauro (D-Conn.)

S.2623: Protecting Americans from Drug Marketing Act

Sponsor: Al Franken (D-Minn.)

H.R.6043: Fair Accountability and Innovative Research Drug Pricing Act of 2016

Sponsor: Jan Schakowsky (D-Ill.)

S.3335: Fair Accountability and Innovative Research Drug Pricing Act of 2016

Sponsor: Tammy Baldwin (D-Wis.)

H.R.1: An Act to provide for reconciliation pursuant to titles II and V of the...

Sponsor: Kevin Brady (R-Texas)

H.R.4385: Responsibility in Drug Advertising Act of 2017

Sponsor: Rosa DeLauro (D-Conn.)

H.R.4116: Transparent Drug Pricing Act of 2017

Sponsor: Lloyd Doggett (D-Texas)

S.2157: Drug-Price Transparency in Communications Act

Sponsor: Richard J. Durbin (D-Ill.)

S.2478: End Taxpayer Subsidies for Drug Ads Act

Sponsor: Claire McCaskill (D-Mo.)

S.73: End Taxpayer Subsidies for Drug Ads Act

Sponsor: Jeanne Shaheen (D-N.H.)

S.1437: Drug-price Transparency in Communications (DTC) Act

Sponsor: Richard J. Durbin (D-Ill.)

H.R.4106: Responsibility in Drug Advertising Act of 2019

Sponsor: Rosa DeLauro (D-Conn.)

H.R.4711: No Tax Breaks for Drug Ads Act

Sponsor: Daniel Lipinski (D-Ill.)

S.2550: No Tax Subsidies for E-Cigarette and Tobacco Ads Act

Sponsor: Jeanne Shaheen (D-N.H.)

S.1801: Affordable Medications Act

Sponsor: Tina Smith (D-Minn.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
James Davidson n/a
Sylvia Kornegay n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Amendment
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page